BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16629161)

  • 1. Molecular and pathological basis of aceruloplasminemia.
    Kono S; Miyajima H
    Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical analysis of a missense mutation in aceruloplasminemia.
    Hellman NE; Kono S; Miyajima H; Gitlin JD
    J Biol Chem; 2002 Jan; 277(2):1375-80. PubMed ID: 11689569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aceruloplasminemia, an iron metabolic disorder.
    Miyajima H
    Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia.
    Kaneko K; Yoshida K; Arima K; Ohara S; Miyajima H; Kato T; Ohta M; Ikeda SI
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1069-77. PubMed ID: 12484569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
    Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aceruloplasminemia].
    Miyajima H
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of heterozygosis for aceruloplasminemia.
    Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract]   [Full Text] [Related]  

  • 15. Criteria for early identification of aceruloplasminemia.
    Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
    Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The copper-iron connection: hereditary aceruloplasminemia.
    Nittis T; Gitlin JD
    Semin Hematol; 2002 Oct; 39(4):282-9. PubMed ID: 12382203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia.
    Klomp LW; Gitlin JD
    Hum Mol Genet; 1996 Dec; 5(12):1989-96. PubMed ID: 8968753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of copper incorporation into human ceruloplasmin.
    Hellman NE; Kono S; Mancini GM; Hoogeboom AJ; De Jong GJ; Gitlin JD
    J Biol Chem; 2002 Nov; 277(48):46632-8. PubMed ID: 12351628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL; Klomp LW; Gitlin JD
    Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aceruloplasminemia, an inherited disorder of iron metabolism.
    Miyajima H; Takahashi Y; Kono S
    Biometals; 2003 Mar; 16(1):205-13. PubMed ID: 12572680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.